Nothing Special   »   [go: up one dir, main page]

Lapensèe, 1992 - Google Patents

A review of schizoaffective disorder: I. Current concepts

Lapensèe, 1992

Document ID
12876337258213964999
Author
Lapensèe M
Publication year
Publication venue
The Canadian Journal of Psychiatry

External Links

Snippet

This paper reviews recent literature on schizoaffective disorder. Research studies of diagnosis, clinical course and outcome and family history are evaluated. It is concluded that schizoaffective disorder is a heterogeneous category which includes patients with bipolar …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry
    • G01N2800/304—Mood disorders, e.g. bipolar, depression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Similar Documents

Publication Publication Date Title
Turvey et al. Long‐term prognosis of bipolar I disorder
Xiong et al. Neurological diseases with autism spectrum disorder: Role of ASD risk genes
Arsov et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies
Känsäkoski et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism
Böhm et al. ORAI1 mutations with distinct channel gating defects in tubular aggregate myopathy
Strous et al. Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects
Lapensèe A review of schizoaffective disorder: I. Current concepts
Hutchinson et al. Morbid risk of schizophrenia in first-degree relatives of white and African–Caribbean patients with psychosis
Bryn et al. Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood
Rosen et al. Positive and negative symptoms in schizophrenia
Minohara et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity
De Marchi et al. Huntington's disease and its association with psychopathology
Pisoni et al. Growth factor proteins and treatment-resistant depression: a place on the path to precision
Zhang et al. Phenotypes in children with SYNGAP1 encephalopathy in China
Petersen et al. Brain-derived neurotrophic factor levels in newly diagnosed patients with bipolar disorder, their unaffected first-degree relatives and healthy controls
Bond Delirium in hospitalized older patients with cancer
Ilinca et al. MAP3K6 mutations in a neurovascular disease causing stroke, cognitive impairment, and tremor
Yang et al. SCN2A-related epilepsy of infancy with migrating focal seizures: report of a variant with apparent gain-and loss-of-function effects
Chumakov et al. A cross-sectional study on associations between BDNF, CRP, IL-6 and clinical symptoms, cognitive and personal performance in patients with paranoid schizophrenia
Lin et al. Severe periodontitis is associated with early-onset poststroke depression status
McGonigal et al. BDNF as potential biomarker of epilepsy severity and psychiatric comorbidity: pitfalls in the clinical population
Yang et al. Decreased neuregulin1β1 in first episode and drug-naïve patients with schizophrenia: negative correlation with cognitive impairment
Wu et al. Plasma PRPC levels correlate with severity and prognosis of intracerebral hemorrhage
Strober Family-genetic aspects of juvenile affective disorders
Jian et al. Circulating naturally occurring antibodies to P2RY2 are decreased in Alzheimer’s disease